Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Multi-center Study Investigating the at Home Administration of Trastuzumab Subcutaneous Vial for the Treatment of Patients With HER2-positive Early Breast Cancer

NCT01926886 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01926886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01926886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Multi-center Study Investigating the at Home Administration of Trastuzumab Subcutaneous Vial for the Treatment of Patients With HER2-positive Early Breast Cancer
Lead sponsor
Hoffmann-La Roche
Phase
Phase 3
Overall status
Completed
Start date
November 19, 2013
Completion date
July 19, 2017
Enrollment
102 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer